A new blood test powered by artificial intelligence (AI) could offer a life-saving head start for patients at high risk…
Articles by Marisa Wexler, MS
An “immuno-gene” therapy that turns a virus into a cancer-fighting agent has received a fast-track designation from the U.S. Food…
People in the U.S. with certain gynecological cancers that are resistant to first-line chemotherapies now have a new treatment option:…
The U.S. Food and Drug Administration (FDA) is reviewing an application from Bristol Myers Squibb (BMS) seeking approval of…
The U.S. Food and Drug Administration (FDA) has approved the combination of two oral therapies, Venclexta (venetoclax) and Calquence (acalabrutinib),…
A cellular recycling process called autophagy helps determine whether pancreatic cancer cells grow quickly or hunker into survival mode…
Telix Pharmaceuticals has submitted an application to European regulators seeking approval for TLX101-Px, the company’s experimental imaging agent designed…
Nuvation Bio expanded a trial testing its experimental therapy, safusidenib, in people with certain forms of glioma that…
In an early clinical trial in the U.S., most women with hard-to-treat ovarian cancer given a low dose of…
Anito-cel (anitocabtagene autoleucel), a cell therapy in clinical development as a potential treatment for myeloma, may be less likely…